RMS General Regression
|
|
9
|
10085
|
June 28, 2022
|
RMS Multivariable Modeling Strategies
|
|
7
|
8533
|
May 15, 2022
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
9
|
4181
|
May 11, 2022
|
Relative excess risk due to interaction (RERI) from a multiplicative model
|
|
3
|
587
|
April 20, 2022
|
Interactions and random error
|
|
15
|
3624
|
July 17, 2021
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
4593
|
December 24, 2020
|
Basic question regarding model specification for interaction testing using a Cox PH Model
|
|
6
|
1936
|
September 23, 2020
|
Subgroup Interaction
|
|
2
|
1632
|
April 8, 2020
|
RCT generalizability and interactions with treatment
|
|
8
|
3417
|
March 10, 2020
|
Bayesian Modeling of Patient-Specific Efficacy Estimates and HTE
|
|
2
|
2866
|
July 2, 2019
|
How to display and tabulate interaction effects in a longitudinal model
|
|
1
|
3444
|
December 14, 2018
|